ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
investment factor · long-only model fund

Foundry DelCOA Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FDERHYPOTHETICAL MODEL
Since ’99
−78%
Expense Ratio
0.35%
placeholder
Holdings
225
cap-weighted
Inception
Dec 2019
placeholder
Full Sharpe
-0.24
Ann. Return (LS)
-4.0%
Ann. Volatility
16.7%
Max Drawdown
-81.1%
Test Sharpe ’19–26
-0.17
Test FF5 α (ann.)
-1.0%
vs Fama-French 5
Test FF5 α t-stat
-0.15
not significant
Monthly turnover
21%
of the long leg, per rebalance
Cumulative return (LS)
-78%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.55
what this fund holds
Long leg ann. return
10.4%
buyable, long-only
Long-short Sharpe
-0.24
requires shorting
Bottom bucket ann. return
14.5%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

225 of 225 · 100.0% of book
TickerCompanySectorMarket capWeight
1NFLX
NETFLIX INCCommunication Services$290.47B
16.26%
2DIS
WALT DISNEY COCommunication Services$169.61B
9.50%
3BA
BOEING COIndustrials$168.72B
9.45%
4SNOW
SNOWFLAKE INCTechnology$93.20B
5.22%
5NDAQ
NASDAQ INCFinancial Services$51.83B
2.90%
6LYV
LIVE NATION ENTERTAINMENT INCCommunication Services$42.45B
2.38%
7COIN
COINBASE GLOBAL INCFinancial Services$41.40B
2.32%
8RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
2.22%
9WDAY
WORKDAY INCTechnology$35.76B
2.00%
10TKO
TKO GROUP HOLDINGS INCCommunication Services$35.38B
1.98%
11MSTR
STRATEGY INCTechnology$33.24B
1.86%
12DXCM
DEXCOM INCHealthcare$29.58B
1.66%
13ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
1.49%
14CPRT
COPART INCIndustrials$25.56B
1.43%
15VRSN
VERISIGN INCTechnology$25.27B
1.41%
16MDB
MONGODB INCTechnology$25.12B
1.41%
17MRNA
MODERNA INCHealthcare$24.53B
1.37%
18DLTR
DOLLAR TREE INCConsumer Defensive$24.20B
1.36%
19FSLR
FIRST SOLAR INCTechnology$22.78B
1.28%
20UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
1.27%
21ASTS
AST SPACEMOBILE INCTechnology$22.43B
1.26%
22IFF
INTERNATIONAL FLAVORS & FRAGRANCES INCBasic Materials$19.96B
1.12%
23APG
API GROUP CORPIndustrials$17.38B
0.97%
24NWSA
NEWS CORPCommunication Services$15.56B
0.87%
25CRCL
CIRCLE INTERNET GROUP INCFinancial Services$15.03B
0.84%
26DECK
DECKERS OUTDOOR CORPConsumer Cyclical$14.79B
0.83%
27BTSG
BRIGHTSPRING HEALTH SERVICES INCHealthcare$13.71B
0.77%
28PINS
PINTEREST INCCommunication Services$13.00B
0.73%
29DKNG
DRAFTKINGS INCConsumer Cyclical$12.37B
0.69%
30AUR
AURORA INNOVATION INCTechnology$11.88B
0.67%
31BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.64%
32HUBS
HUBSPOT INCTechnology$11.49B
0.64%
33HUT
HUT 8 CORPFinancial Services$10.30B
0.58%
34GTLS
CHART INDUSTRIES INCIndustrials$10.05B
0.56%
35CYTK
CYTOKINETICS INCHealthcare$9.98B
0.56%
36MSGS
MADISON SQUARE GARDEN SPORTS CORPCommunication Services$9.56B
0.54%
37BMNR
BITMINE IMMERSION TECHNOLOGIES INCFinancial Services$9.46B
0.53%
38LTH
LIFE TIME GROUP HOLDINGS INCConsumer Cyclical$9.38B
0.53%
39HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.52%
40PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.51%
41TTC
TORO COIndustrials$8.99B
0.50%
42LUMN
LUMEN TECHNOLOGIES INCCommunication Services$6.47B
0.36%
43SRRK
SCHOLAR ROCK HOLDING CORPHealthcare$6.33B
0.35%
44IBP
INSTALLED BUILDING PRODUCTS INCConsumer Cyclical$6.16B
0.34%
45FBIN
FORTUNE BRANDS INNOVATIONS INCBasic Materials$6.14B
0.34%
46MYRG
MYR GROUP INCIndustrials$6.10B
0.34%
47ERAS
ERASCA INCHealthcare$5.96B
0.33%
48LYFT
LYFT INCTechnology$5.89B
0.33%
49CHDN
CHURCHILL DOWNS INCConsumer Cyclical$5.85B
0.33%
50ENPH
ENPHASE ENERGY INCTechnology$5.48B
0.31%
51MTN
VAIL RESORTS INCConsumer Cyclical$5.27B
0.30%
52SPHR
SPHERE ENTERTAINMENT COCommunication Services$5.10B
0.29%
53DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.27%
54PRIM
PRIMORIS SERVICES CORPIndustrials$4.66B
0.26%
55KBR
KBR INCIndustrials$4.45B
0.25%
56IPGP
IPG PHOTONICS CORPTechnology$4.43B
0.25%
57VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.24%
58PI
IMPINJ INCTechnology$4.21B
0.24%
59GPGI
GPGI INCIndustrials$4.21B
0.24%
60ACLS
AXCELIS TECHNOLOGIES INCTechnology$4.19B
0.23%
61PLNT
PLANET FITNESS INCConsumer Cyclical$4.16B
0.23%
62LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.23%
63ICUI
ICU MEDICAL INCHealthcare$3.94B
0.22%
64DOCS
DOXIMITY INCHealthcare$3.94B
0.22%
65POWI
POWER INTEGRATIONS INCTechnology$3.93B
0.22%
66TDS
TELEPHONE & DATA SYSTEMS INCCommunication Services$3.90B
0.22%
67RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.21%
68OLED
UNIVERSAL DISPLAY CORPTechnology$3.75B
0.21%
69DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.21%
70BATRA
ATLANTA BRAVES HOLDINGS INCCommunication Services$3.63B
0.20%
71MSGE
MADISON SQUARE GARDEN ENTERTAINMENT CORPConsumer Cyclical$3.56B
0.20%
72CNK
CINEMARK HOLDINGS INCCommunication Services$3.55B
0.20%
73XXI
TWENTY ONE CAPITAL INCIndustrials$3.48B
0.19%
74RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.19%
75SEDG
SOLAREDGE TECHNOLOGIES INCTechnology$3.25B
0.18%
76EEFT
EURONET WORLDWIDE INCTechnology$3.10B
0.17%
77LEU
CENTRUS ENERGY CORPBasic Materials$3.07B
0.17%
78AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.17%
79FRSH
FRESHWORKS INCTechnology$3.01B
0.17%
80RARE
ULTRAGENYX PHARMACEUTICAL INCHealthcare$2.88B
0.16%
81DAN
DANA INCConsumer Cyclical$2.87B
0.16%
82CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.16%
83VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.15%
84TNET
TRINET GROUP INCIndustrials$2.74B
0.15%
85VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.15%
86OSW
ONESPAWORLD HOLDINGS LTDConsumer Cyclical$2.68B
0.15%
87IMNM
IMMUNOME INCHealthcare$2.53B
0.14%
88PGNY
PROGYNY INCHealthcare$2.50B
0.14%
89NRIX
NURIX THERAPEUTICS INCHealthcare$2.40B
0.13%
90BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.13%
91AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.13%
92BHVN
BIOHAVEN LTDHealthcare$2.32B
0.13%
93IOVA
IOVANCE BIOTHERAPEUTICS INCHealthcare$2.23B
0.13%
94SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.12%
95AGL
AGILON HEALTH INCHealthcare$2.17B
0.12%
96PRKS
UNITED PARKS & RESORTS INCConsumer Cyclical$2.13B
0.12%
97PPTA
PERPETUA RESOURCES CORPBasic Materials$2.11B
0.12%
98CDNA
CAREDX INCHealthcare$2.05B
0.11%
99SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.11%
100AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.11%
101CPRI
CAPRI HOLDINGS LTDConsumer Cyclical$1.89B
0.11%
102NVCR
NOVOCURE LTDHealthcare$1.84B
0.10%
103SRPT
SAREPTA THERAPEUTICS INCHealthcare$1.82B
0.10%
104ZYME
ZYMEWORKS INCHealthcare$1.77B
0.10%
105ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.09%
106TE
T1 ENERGY INCIndustrials$1.63B
0.09%
107INVA
INNOVIVA INCHealthcare$1.60B
0.09%
108VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.09%
109NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.09%
110INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.08%
111TRS
TRIMAS CORPConsumer Cyclical$1.46B
0.08%
112MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.08%
113ARLO
ARLO TECHNOLOGIES INCBasic Materials$1.45B
0.08%
114YELP
YELP INCCommunication Services$1.44B
0.08%
115AI
C3AI INCTechnology$1.37B
0.08%
116CXM
SPRINKLR INCTechnology$1.37B
0.08%
117BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.08%
118FCEL
FUELCELL ENERGY INCIndustrials$1.25B
0.07%
119CMP
COMPASS MINERALS INTERNATIONAL INCBasic Materials$1.24B
0.07%
120SDGR
SCHRODINGER INCHealthcare$1.14B
0.06%
121CRTO
CRITEO SACommunication Services$1.13B
0.06%
122UPWK
UPWORK INCIndustrials$1.12B
0.06%
123EYPT
EYEPOINT INCHealthcare$1.12B
0.06%
124CRSR
CORSAIR GAMING INCTechnology$1.04B
0.06%
125LUCK
LUCKY STRIKE ENTERTAINMENT CORPConsumer Cyclical$1.01B
0.06%
126PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.06%
127ACEL
ACCEL ENTERTAINMENT INCConsumer Cyclical$989M
0.06%
128KURA
KURA ONCOLOGY INCHealthcare$964M
0.05%
129ANNX
ANNEXON INCHealthcare$950M
0.05%
130REPL
REPLIMUNE GROUP INCHealthcare$859M
0.05%
131MATW
MATTHEWS INTERNATIONAL CORPIndustrials$857M
0.05%
132CYRX
CRYOPORT INCIndustrials$832M
0.05%
133CODI
COMPASS DIVERSIFIED HOLDINGSIndustrials$777M
0.04%
134BBNX
BETA BIONICS INCHealthcare$771M
0.04%
135GDOT
GREEN DOT CORPFinancial Services$760M
0.04%
136KRO
KRONOS WORLDWIDE INCBasic Materials$757M
0.04%
137IBTA
IBOTTA INCTechnology$734M
0.04%
138AURA
AURA BIOSCIENCES INCHealthcare$723M
0.04%
139MCS
MARCUS CORPCommunication Services$708M
0.04%
140SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.04%
141PKE
PARK AEROSPACE CORPIndustrials$677M
0.04%
142RSVR
RESERVOIR MEDIA INCCommunication Services$671M
0.04%
143SWBI
SMITH & WESSON BRANDS INCIndustrials$665M
0.04%
144CNNE
CANNAE HOLDINGS INCConsumer Cyclical$657M
0.04%
145TREE
LENDINGTREE INCFinancial Services$645M
0.04%
146ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.04%
147PUBM
PUBMATIC INCTechnology$591M
0.03%
148NGNE
NEUROGENE INCHealthcare$590M
0.03%
149ETD
ETHAN ALLEN INTERIORS INCConsumer Cyclical$580M
0.03%
150MLR
MILLER INDUSTRIES INCConsumer Cyclical$566M
0.03%
151EGY
VAALCO ENERGY INCEnergy$553M
0.03%
152WNC
WABASH NATIONAL CORPIndustrials$547M
0.03%
153PKOH
PARK OHIO HOLDINGS CORPIndustrials$544M
0.03%
154ORN
ORION GROUP HOLDINGS INCIndustrials$518M
0.03%
155ARVN
ARVINAS INCHealthcare$517M
0.03%
156SPIR
SPIRE GLOBAL INCIndustrials$488M
0.03%
157SGMT
SAGIMET BIOSCIENCES INCHealthcare$479M
0.03%
158STRZ
STARZ ENTERTAINMENT CORPCommunication Services$450M
0.03%
159TITN
TITAN MACHINERY INCIndustrials$446M
0.02%
160SRTA
STRATA CRITICAL MEDICAL INCIndustrials$446M
0.02%
161BNED
BARNES & NOBLE EDUCATION INCConsumer Cyclical$437M
0.02%
162CCRN
CROSS COUNTRY HEALTHCARE INCHealthcare$428M
0.02%
163ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.02%
164CLFD
CLEARFIELD INCTechnology$416M
0.02%
165MCFT
MASTERCRAFT BOAT HOLDINGS INCConsumer Cyclical$407M
0.02%
166ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.02%
167EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.02%
168STRO
SUTRO BIOPHARMA INCHealthcare$391M
0.02%
169ABTC
AMERICAN BITCOIN CORPFinancial Services$386M
0.02%
170UPB
UPSTREAM BIO INCHealthcare$382M
0.02%
171ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.02%
172MTRX
MATRIX SERVICE COIndustrials$342M
0.02%
173RTAC
RENATUS TACTICAL ACQUISITION CORP IIndustrials$329M
0.02%
174XPOF
XPONENTIAL FITNESS INCConsumer Cyclical$328M
0.02%
175VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.02%
176VELO
VELO3D INCTechnology$316M
0.02%
177MKTW
MARKETWISE INCTechnology$314M
0.02%
178OSS
ONE STOP SYSTEMS INCTechnology$313M
0.02%
179BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.02%
180FHTX
FOGHORN THERAPEUTICS INCHealthcare$305M
0.02%
181ALCO
ALICO INCConsumer Defensive$304M
0.02%
182TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.02%
183TSSI
TSS INCTechnology$274M
0.02%
184AVNW
AVIAT NETWORKS INCTechnology$269M
0.02%
185TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.01%
186ALMU
AELUMA INCTechnology$267M
0.01%
187SVCO
SILVACO GROUP INCTechnology$260M
0.01%
188TBCH
TURTLE BEACH CORPTechnology$258M
0.01%
189VNME
VENDOME ACQUISITION CORP IIndustrials$254M
0.01%
190ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.01%
191QUIK
QUICKLOGIC CORPTechnology$237M
0.01%
192ALOT
ASTRONOVA INCTechnology$222M
0.01%
193KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.01%
194KROS
KEROS THERAPEUTICS INCHealthcare$211M
0.01%
195SRI
STONERIDGE INCConsumer Cyclical$197M
0.01%
196EAF
GRAFTECH INTERNATIONAL LTDIndustrials$181M
0.01%
197KVHI
KVH INDUSTRIES INCTechnology$178M
0.01%
198ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.01%
199RCEL
AVITA MEDICAL INCHealthcare$157M
0.01%
200HOFT
HOOKER FURNISHINGS CORPConsumer Cyclical$152M
0.01%
201ACNT
ASCENT INDUSTRIES COBasic Materials$138M
0.01%
202PMN
PROMIS NEUROSCIENCES INCHealthcare$136M
0.01%
203DMRC
DIGIMARC CORPTechnology$133M
0.01%
204AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.01%
205JYNT
JOINT CORPHealthcare$127M
0.01%
206VATE
INNOVATE CORPIndustrials$123M
0.01%
207SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.01%
208UFI
UNIFI INCConsumer Cyclical$118M
0.01%
209SSTI
SOUNDTHINKING INCTechnology$111M
0.01%
210MHH
MASTECH DIGITAL INCIndustrials$89M
0.00%
211GEOS
GEOSPACE TECHNOLOGIES CORPEnergy$88M
0.00%
212RLYB
RALLYBIO CORPHealthcare$87M
0.00%
213CPHC
CANTERBURY PARK HOLDING CORPConsumer Cyclical$82M
0.00%
214DLHC
DLH HOLDINGS CORPIndustrials$80M
0.00%
215LFVN
LIFEVANTAGE CORPConsumer Defensive$78M
0.00%
216SEAT
VIVID SEATS INCCommunication Services$78M
0.00%
217ACET
ADICET BIO INCHealthcare$76M
0.00%
218ATRA
ATARA BIOTHERAPEUTICS INCHealthcare$76M
0.00%
219BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.00%
220BGSF
BGSF INCIndustrials$65M
0.00%
221BRID
BRIDGFORD FOODS CORPConsumer Defensive$59M
0.00%
222LNZA
LANZATECH GLOBAL INCIndustrials$56M
0.00%
223TACT
TRANSACT TECHNOLOGIES INCTechnology$54M
0.00%
224ACFN
ACORN ENERGY INCTechnology$51M
0.00%
225TIL
INSTIL BIO INCHealthcare$50M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $1.79T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

9 sectors
Communication Services
34.2%
Technology
18.7%
Industrials
16.6%
Healthcare
15.5%
Financial Services
7.3%
Consumer Cyclical
4.4%
Basic Materials
2.0%
Consumer Defensive
1.4%
Energy
0.0%

Portfolio Style

Size × value map of the long-leg book

225 classified
Value
Blend
Growth
Large
Mid
Small
14%6
31%15
34%24
2%19
4%30
4%27
1%40
<1%23
<1%18

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 92% toward Large, 62% toward Growth. +10% unclassified (23 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt92% → Large
SmallLarge
Value ↔ growth tilt62% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 225 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
3
Failed
2
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    34.4%
    Margin
    -9.4%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 225 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.4 (95% CI 1.0-1.8)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
13.5%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.41x
within
parametric
1.21x
within
cornish fisher
1.23x
within

The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 16%; both still land on the same side of the 2x limit.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2005
Before publication (pre-2005)
-0.33
Sharpe · -7.3% p.a.
January 1999December 2005 · 84 mo
Since publication
-0.20
Sharpe · -2.9% p.a.
January 2006July 2026 · 247 mo
Change in Sharpe+0.12Sharpe strengthened since publication

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
27%
7 of 26 3-year windows made money
Worst window
-1.41
Sharpe, January 2005 – December 2007
January 1999July 2026
Median Sharpe
-0.23
Dispersion
0.55
Best window
1.05

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.21.6%7.7%
3 yearsp.a.18.6%-13.4%
5 yearsp.a.12.8%-4.7%
10 yearsp.a.16.5%-5.9%
Since inceptionp.a.9.0%-5.3%
Calendar years
YearLong legLong-short
20267 mo7.8%6.1%
202521.9%-15.9%
202413.3%-36.0%
202369.2%23.5%
2022-32.8%11.0%
202131.0%2.9%
202035.2%-15.3%
201931.0%-0.7%
2018-10.0%-8.8%
201728.4%-11.1%
20169.1%3.2%
20154.2%1.4%
201415.9%-1.9%
201341.2%-1.9%
201216.6%10.6%
20115.4%6.7%
201025.2%13.6%
200934.2%-11.1%
2008-39.2%-5.5%
200712.1%-21.1%
200613.8%-9.1%
20050.8%-10.2%
20042.6%-8.5%
200338.5%7.3%
2002-36.9%-22.3%
2001-7.6%3.0%
2000-31.9%-8.0%
199938.6%-23.4%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FDER
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2019-12-11 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$1.79T

Methodology

The Foundry DelCOA Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a DelCOA signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.